The protective activity of noscapine on renal ischemia-reperfusion injury in male Wistar rat

Iranian Journal of Basic Medical Sciences

Volumn 17, Issue 4, 2014, Pages 244-249

  Khanmoradi, Mehrangiz ^a   Mard, Seyyed Ali ^b   Aboutaleb, Nahid ^a   Nobakht, Malihe ^c   Mahmoudian, Masoud ^c  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bun; Creatinine; Noscapine; Rat; Renal ischemia reperfusion injury

Indexed keywords

BETA ACTIN; CREATININE; MONOCYTE CHEMOTACTIC PROTEIN 1; NOSCAPINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXSANGUINATION; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; LAPAROTOMY; MALE; NEPHRECTOMY; NONHUMAN; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REPERFUSION; REPERFUSION INJURY; TISSUE STRUCTURE; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

EID: 84898815178     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004; 351:2715-2729.
2. Naka Y, Roy DK, Smerling AJ, Michler RE, Smith CR, Stern DM, Oz MC, Pinsky DJ. Inhaled nitric oxide fails to confer the pulmonary protection provided by distal stimulation of the nitric oxide pathway at the level of cyclic guanosine monophosphate. J Thorac Cardiovasc Surg 1995; 110:1434-1441.
3. Hashimoto N, Takeyoshi I, Tsutsumi H, Sunose Y, Tokumine M, Totsuka O, et al. Effects of a bradykinin B(2) receptor antagonist on ischemia-reperfusion injury in a canine lung transplantation model. J Heart Lung Transplant 2004; 23:606-613.
4. Totsuka O, Takeyoshi I, Tsutsumi H, Hashimoto N, Sunose Y, Tokumine M, et al. The effects of a bradykinin B2 receptor antagonist in extended liver resection with ischemia in dogs. Hepatogastroenterology 2004; 51:1771-1775.
5. Souza DG, Pinho V, Pesquero JL, Lomez ES, Poole S, Juliano L, et al. Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury. Br J Pharmacol 2003; 139:129-139.
6. Arakawa K, Takeyoshi I, Akao Y, Totsuka O, Matsumoto K, Morishita Y. Bradykinin B2 receptor antagonist FR173657 ameliorates small bowel ischemia-reperfusion injury in dogs. Dig Dis Sci 2005; 50:27-36.
7. Chiang WC, Chien CT, Lin WW, Lin SL, Chen YM, Lai CF, et al. Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury. Free Radic Biol Med 2006; 41:1304-1314.
8. Mahmoudian M, Siadatpour Z, Ziai SA, Mehrpour M, Benaissa F, Nobakht M., Reduction of the prenatal hypoxic-ischemic brain edema with noscapine. Acta Physiol Hung 2003; 90:313-318.
9. Solez K, Racusen LC, Whelton A. Glomerular epithelial cell changes in early postischemic acute renal failure in rabbits and man. Am J Pathol 1981; 103:163-173.
10. Villanueva S, Céspedes C, Vio CP. Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. Am J Physiol Regul Integr Comp Physiol 2006; 290:R861-870.
11. Wirth K, Hock FJ, Albus U, Linz W, Alpermann HG, Anagnostopoulos H, et al. Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol 1991; 102:774-777.
12. Mahmoudian M, Mehrpour M, Benaissa F, Siadatpour Z. A preliminary report on the application of noscapine in the treatment of stroke. Eur J Clin Pharmacol 2003; 59:579-581.
13. Ke Y, Ye K, Grossniklaus HE, Archer DR, Joshi HC, Kapp JA. Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses. Cancer Immunol Immunother 2000; 49:217-225.
14. Zughaier S, Karna P, Stephens D, Aneja R. Potent anti-inflammatory activity of novel microtubule-modulating brominated noscapine analogs. PLoS One 2010; 11:e9165.
15. Ebrahimi SA, Zareie MR, Rostami P, Mahmoudian M. Interaction of noscapine with the bradykinin mediation of the cough response. Acta Physiol Hung 2003; 90:147-155.
16. Aneja R, Dhiman N, Idnani J, Awasthi A, Arora SK, Chandra R, et al. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent. Cancer Chemother Pharmacol 2007; 60:831-839.
17. Zhou J, Gupta K, Aggarwal S, Aneja R, Chandra R, Panda D, et al. Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation. Mol Pharmacol 2003; 63:799-807.
18. Tomasoni S, Azzollini N, Casiraghi F, Capogrossi MC, Remuzzi G, Benigni A. CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft. J Am Soc Nephrol 2000; 11:747-752.
19. Wolf G, Aberle S, Thaiss F, Nelson PJ, Krensky AM, Neilson EG, et al. TNF alpha induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. Kidney Int 1993; 44:795-804.
20. Prasad P, Tiwari AK, Kumar KM, Ammini AC, Gupta A, Gupta R, et al. Association of TGFbeta1, TNF-alpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians. BMC Med Genet 2007; 12:20.
21. Jiang S, Tang Q, Rong R, Tang L, Xu M, Lu J, et al. Mycophenolate mofetil inhibits macrophage infiltration and kidney fibrosis in long-term ischemia-reperfusion injury. Eur J Pharmacol 2012; 688:56-61.
22. Jia Y, Zhao Z, Xu M, Zhao T, Qiu Y, Ooi Y, et al. Prevention of renal ischemia-reperfusion injury by short hairpin RNA of endothelin A receptor in a rat model. Exp Biol Med 2012; 1:894-902.